The latest price target for Repligen (NASDAQ:RGEN) was reported by Benchmark on July 7, 2026. The analyst firm set a price target for $185.00 expecting RGEN to rise to within 12 months (a possible ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Repligen (NASDAQ:RGEN) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ...
Tuesday, Repligen Corporation (NASDAQ:RGEN) reported second-quarter sales of $154.1 million, almost in line with the consensus estimate of $154.12 million. The company reported second-quarter adjusted ...
During the last three months, 5 analysts shared their evaluations of Repligen (NASDAQ:RGEN), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ratings, ...
Repligen Earnings: Double-Digit Revenue Growth and Margin Improvement To Continue in 2026 Repligen reported year-on-year revenue growth of 14% for the quarter and 16% for the year. Full-year adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results